APO Research

APO RESEARCH · REPORT

Donepezil Hydrochloride Tablet

Selected research

Market Structure

Global Donepezil Hydrochloride Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Donepezil Hydrochloride Tablet market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Donepezil Hydrochloride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Donepezil Hydrochloride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Donepezil Hydrochloride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Donepezil Hydrochloride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Donepezil Hydrochloride Tablet include Eisai, Luoxin Pharmaceutical, Pfizer, Huahai Pharmaceutical, Hansoh Pharma, Hisun Pharmaceutical, ARK PHA.LTD, Lupin and Globalstar, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Donepezil Hydrochloride Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Donepezil Hydrochloride Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Donepezil Hydrochloride Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Donepezil Hydrochloride Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.

Donepezil Hydrochloride Tablet Segment by Company

Eisai

Luoxin Pharmaceutical

Pfizer

Huahai Pharmaceutical

Hansoh Pharma

Hisun Pharmaceutical

ARK PHA.LTD

Lupin

Globalstar

G Med Impex

Donepezil Hydrochloride Tablet Segment by Type

5 mg/tablet

10 mg/tablet

Donepezil Hydrochloride Tablet Segment by Application

Hospitals

Drugstores

Others

Donepezil Hydrochloride Tablet Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Donepezil Hydrochloride Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Donepezil Hydrochloride Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Donepezil Hydrochloride Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Donepezil Hydrochloride Tablet market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Donepezil Hydrochloride Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Donepezil Hydrochloride Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Donepezil Hydrochloride Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Donepezil Hydrochloride Tablet Industry Trends Table 2. Donepezil Hydrochloride Tablet Industry Drivers Table 3. Donepezil Hydrochloride Tablet Industry Opportunities and Challenges Table 4. Donepezil Hydrochloride Tablet Industry Restraints Table 5. Global Donepezil Hydrochloride Tablet Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Donepezil Hydrochloride Tablet Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Donepezil Hydrochloride Tablet Sales by Manufacturers (K Pcs) & (2021-2026) Table 8. Global Donepezil Hydrochloride Tablet Sales Market Share by Manufacturers Table 9. Global Donepezil Hydrochloride Tablet Average Sales Price (US$/Pcs) of Manufacturers (2021-2026) Table 10. Global Donepezil Hydrochloride Tablet Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Donepezil Hydrochloride Tablet Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Donepezil Hydrochloride Tablet Manufacturers, Product Type & Application Table 13. Global Donepezil Hydrochloride Tablet Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Donepezil Hydrochloride Tablet by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 5 mg/tablet Table 17. Major Manufacturers of 10 mg/tablet Table 18. Global Donepezil Hydrochloride Tablet Sales by Type 2021 VS 2025 VS 2032 (K Pcs) Table 19. Global Donepezil Hydrochloride Tablet Sales by Type (2021-2026) & (K Pcs) Table 20. Global Donepezil Hydrochloride Tablet Sales by Type (2027-2032) & (K Pcs) Table 21. Global Donepezil Hydrochloride Tablet Sales Market Share by Type (2021-2026) Table 22. Global Donepezil Hydrochloride Tablet Sales Market Share by Type (2027-2032) Table 23. Global Donepezil Hydrochloride Tablet Revenue by Type 2021 VS 2025 VS 2032 (K Pcs) Table 24. Global Donepezil Hydrochloride Tablet Revenue by Type (2021-2026) & (K Pcs) Table 25. Global Donepezil Hydrochloride Tablet Revenue by Type (2027-2032) & (K Pcs) Table 26. Global Donepezil Hydrochloride Tablet Revenue Market Share by Type (2021-2026) Table 27. Global Donepezil Hydrochloride Tablet Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospitals Table 29. Major Manufacturers of Drugstores Table 30. Major Manufacturers of Others Table 31. Global Donepezil Hydrochloride Tablet Sales by Application 2021 VS 2025 VS 2032 (K Pcs) Table 32. Global Donepezil Hydrochloride Tablet Sales by Application (2021-2026) & (K Pcs) Table 33. Global Donepezil Hydrochloride Tablet Sales by Application (2027-2032) & (K Pcs) Table 34. Global Donepezil Hydrochloride Tablet Sales Market Share by Application (2021-2026) Table 35. Global Donepezil Hydrochloride Tablet Sales Market Share by Application (2027-2032) Table 36. Global Donepezil Hydrochloride Tablet Revenue by Application 2021 VS 2025 VS 2032 (K Pcs) Table 37. Global Donepezil Hydrochloride Tablet Revenue by Application (2021-2026) & (K Pcs) Table 38. Global Donepezil Hydrochloride Tablet Revenue by Application (2027-2032) & (K Pcs) Table 39. Global Donepezil Hydrochloride Tablet Revenue Market Share by Application (2021-2026) Table 40. Global Donepezil Hydrochloride Tablet Revenue Market Share by Application (2027-2032) Table 41. Global Donepezil Hydrochloride Tablet Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Table 42. Global Donepezil Hydrochloride Tablet Sales by Region (2021-2026) & (K Pcs) Table 43. Global Donepezil Hydrochloride Tablet Sales Market Share by Region (2021-2026) Table 44. Global Donepezil Hydrochloride Tablet Sales Forecasted by Region (2027-2032) & (K Pcs) Table 45. Global Donepezil Hydrochloride Tablet Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Donepezil Hydrochloride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 47. North America Donepezil Hydrochloride Tablet Sales by Country (2021-2026) & (K Pcs) Table 48. North America Donepezil Hydrochloride Tablet Sales by Country (2027-2032) & (K Pcs) Table 49. Europe Donepezil Hydrochloride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 50. Europe Donepezil Hydrochloride Tablet Sales by Country (2021-2026) & (K Pcs) Table 51. Europe Donepezil Hydrochloride Tablet Sales by Country (2027-2032) & (K Pcs) Table 52. Asia Pacific Donepezil Hydrochloride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 53. Asia Pacific Donepezil Hydrochloride Tablet Sales by Country (2021-2026) & (K Pcs) Table 54. Asia Pacific Donepezil Hydrochloride Tablet Sales by Country (2027-2032) & (K Pcs) Table 55. South America, Middle East and Africa Donepezil Hydrochloride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 56. South America, Middle East and Africa Donepezil Hydrochloride Tablet Sales by Country (2021-2026) & (K Pcs) Table 57. South America, Middle East and Africa Donepezil Hydrochloride Tablet Sales by Country (2027-2032) & (K Pcs) Table 58. Global Donepezil Hydrochloride Tablet Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Donepezil Hydrochloride Tablet Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Donepezil Hydrochloride Tablet Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Donepezil Hydrochloride Tablet Revenue Market Share by Region (2021-2026) Table 62. Global Donepezil Hydrochloride Tablet Revenue Market Share by Region (2027-2032) Table 63. Eisai Company Information Table 64. Eisai Business Overview Table 65. Eisai Donepezil Hydrochloride Tablet Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Eisai Donepezil Hydrochloride Tablet Product Portfolio Table 67. Eisai Recent Development Table 68. Luoxin Pharmaceutical Company Information Table 69. Luoxin Pharmaceutical Business Overview Table 70. Luoxin Pharmaceutical Donepezil Hydrochloride Tablet Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Luoxin Pharmaceutical Donepezil Hydrochloride Tablet Product Portfolio Table 72. Luoxin Pharmaceutical Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Donepezil Hydrochloride Tablet Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Pfizer Donepezil Hydrochloride Tablet Product Portfolio Table 77. Pfizer Recent Development Table 78. Huahai Pharmaceutical Company Information Table 79. Huahai Pharmaceutical Business Overview Table 80. Huahai Pharmaceutical Donepezil Hydrochloride Tablet Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Huahai Pharmaceutical Donepezil Hydrochloride Tablet Product Portfolio Table 82. Huahai Pharmaceutical Recent Development Table 83. Hansoh Pharma Company Information Table 84. Hansoh Pharma Business Overview Table 85. Hansoh Pharma Donepezil Hydrochloride Tablet Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hansoh Pharma Donepezil Hydrochloride Tablet Product Portfolio Table 87. Hansoh Pharma Recent Development Table 88. Hisun Pharmaceutical Company Information Table 89. Hisun Pharmaceutical Business Overview Table 90. Hisun Pharmaceutical Donepezil Hydrochloride Tablet Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Hisun Pharmaceutical Donepezil Hydrochloride Tablet Product Portfolio Table 92. Hisun Pharmaceutical Recent Development Table 93. ARK PHA.LTD Company Information Table 94. ARK PHA.LTD Business Overview Table 95. ARK PHA.LTD Donepezil Hydrochloride Tablet Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. ARK PHA.LTD Donepezil Hydrochloride Tablet Product Portfolio Table 97. ARK PHA.LTD Recent Development Table 98. Lupin Company Information Table 99. Lupin Business Overview Table 100. Lupin Donepezil Hydrochloride Tablet Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Lupin Donepezil Hydrochloride Tablet Product Portfolio Table 102. Lupin Recent Development Table 103. Globalstar Company Information Table 104. Globalstar Business Overview Table 105. Globalstar Donepezil Hydrochloride Tablet Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Globalstar Donepezil Hydrochloride Tablet Product Portfolio Table 107. Globalstar Recent Development Table 108. G Med Impex Company Information Table 109. G Med Impex Business Overview Table 110. G Med Impex Donepezil Hydrochloride Tablet Sales (K Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. G Med Impex Donepezil Hydrochloride Tablet Product Portfolio Table 112. G Med Impex Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Donepezil Hydrochloride Tablet Distributors List Table 116. Donepezil Hydrochloride Tablet Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Donepezil Hydrochloride Tablet Product Image Figure 2. Global Donepezil Hydrochloride Tablet Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Donepezil Hydrochloride Tablet Market Size (2021-2032) & (US$ Million) Figure 4. Global Donepezil Hydrochloride Tablet Sales (2021-2032) & (K Pcs) Figure 5. Global Donepezil Hydrochloride Tablet Average Price (US$/Pcs) & (2021-2032) Figure 6. Global Top 5 and 10 Donepezil Hydrochloride Tablet Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 5 mg/tablet Image Figure 9. 10 mg/tablet Image Figure 10. Global Donepezil Hydrochloride Tablet Sales by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 11. Global Donepezil Hydrochloride Tablet Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Donepezil Hydrochloride Tablet Sales Market Share by Type (2021-2032) Figure 13. Global Donepezil Hydrochloride Tablet Revenue by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 14. Global Donepezil Hydrochloride Tablet Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Donepezil Hydrochloride Tablet Revenue Market Share by Type (2021-2032) Figure 16. Hospitals Image Figure 17. Drugstores Image Figure 18. Others Image Figure 19. Global Donepezil Hydrochloride Tablet Sales by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 20. Global Donepezil Hydrochloride Tablet Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Donepezil Hydrochloride Tablet Sales Market Share by Application (2021-2032) Figure 22. Global Donepezil Hydrochloride Tablet Revenue by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 23. Global Donepezil Hydrochloride Tablet Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Donepezil Hydrochloride Tablet Revenue Market Share by Application (2021-2032) Figure 25. North America Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 26. North America Donepezil Hydrochloride Tablet Sales Market Share by Country (2021-2032) Figure 27. U.S. Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 28. Canada Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 29. Mexico Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 30. Europe Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 31. Europe Donepezil Hydrochloride Tablet Sales Market Share by Country (2021-2032) Figure 32. Germany Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 33. France Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 34. U.K. Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 35. Italy Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 36. Netherlands Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 37. Asia Pacific Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 38. Asia Pacific Donepezil Hydrochloride Tablet Sales Market Share by Country (2021-2032) Figure 39. China Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 40. Japan Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 41. South Korea Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 42. Southeast Asia Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 43. India Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 44. Australia Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 45. South America, Middle East and Africa Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 46. South America, Middle East and Africa Donepezil Hydrochloride Tablet Sales Market Share by Country (2021-2032) Figure 47. Brazil Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 48. South Africa Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 49. Saudi Arabia Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 50. Turkey Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 51. Argentina Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 52. UAE Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 53. Egypt Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 54. Chile Donepezil Hydrochloride Tablet Sales and Growth Rate (2021-2032) & (K Pcs) Figure 55. Global Donepezil Hydrochloride Tablet Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Donepezil Hydrochloride Tablet Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Donepezil Hydrochloride Tablet Revenue (2021-2032) & (US$ Million) Figure 58. North America Donepezil Hydrochloride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Donepezil Hydrochloride Tablet Revenue (2021-2032) & (US$ Million) Figure 60. Europe Donepezil Hydrochloride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Donepezil Hydrochloride Tablet Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Donepezil Hydrochloride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Donepezil Hydrochloride Tablet Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Donepezil Hydrochloride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Donepezil Hydrochloride Tablet Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Donepezil Hydrochloride Tablet Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 5 mg/tablet
  • 10 mg/tablet
Applications
  • Hospitals
  • Drugstores
  • Others
Companies covered
  • Eisai
  • Luoxin Pharmaceutical
  • Pfizer
  • Huahai Pharmaceutical
  • Hansoh Pharma
  • Hisun Pharmaceutical
  • ARK PHA.LTD
  • Lupin
  • Globalstar
  • G Med Impex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Donepezil Hydrochloride Tablet Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Donepezil Hydrochloride Tablet Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Donepezil Hydrochloride Tablet Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Donepezil Hydrochloride Tablet Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Donepezil Hydrochloride Tablet Market Dynamics
  1. 2.1 Donepezil Hydrochloride Tablet Industry Trends
  2. 2.2 Donepezil Hydrochloride Tablet Industry Drivers
  3. 2.3 Donepezil Hydrochloride Tablet Industry Opportunities and Challenges
  4. 2.4 Donepezil Hydrochloride Tablet Industry Restraints
3 Donepezil Hydrochloride Tablet Market by Manufacturers
  1. 3.1 Global Donepezil Hydrochloride Tablet Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Donepezil Hydrochloride Tablet Sales by Manufacturers (2021-2026)
  3. 3.3 Global Donepezil Hydrochloride Tablet Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Donepezil Hydrochloride Tablet Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Donepezil Hydrochloride Tablet Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Donepezil Hydrochloride Tablet Manufacturers, Product Type & Application
  7. 3.7 Global Donepezil Hydrochloride Tablet Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Donepezil Hydrochloride Tablet Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Donepezil Hydrochloride Tablet Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Donepezil Hydrochloride Tablet Tier 1, Tier 2, and Tier 3
4 Donepezil Hydrochloride Tablet Market by Type
  1. 4.1 Donepezil Hydrochloride Tablet Type Introduction
  2. 4.1.1 5 mg/tablet
  3. 4.1.2 10 mg/tablet
  4. 4.2 Global Donepezil Hydrochloride Tablet Sales by Type
  5. 4.2.1 Global Donepezil Hydrochloride Tablet Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Donepezil Hydrochloride Tablet Sales by Type (2021-2032)
  7. 4.2.3 Global Donepezil Hydrochloride Tablet Sales Market Share by Type (2021-2032)
  8. 4.3 Global Donepezil Hydrochloride Tablet Revenue by Type
  9. 4.3.1 Global Donepezil Hydrochloride Tablet Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Donepezil Hydrochloride Tablet Revenue by Type (2021-2032)
  11. 4.3.3 Global Donepezil Hydrochloride Tablet Revenue Market Share by Type (2021-2032)
5 Donepezil Hydrochloride Tablet Market by Application
  1. 5.1 Donepezil Hydrochloride Tablet Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Drugstores
  4. 5.1.3 Others
  5. 5.2 Global Donepezil Hydrochloride Tablet Sales by Application
  6. 5.2.1 Global Donepezil Hydrochloride Tablet Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Donepezil Hydrochloride Tablet Sales by Application (2021-2032)
  8. 5.2.3 Global Donepezil Hydrochloride Tablet Sales Market Share by Application (2021-2032)
  9. 5.3 Global Donepezil Hydrochloride Tablet Revenue by Application
  10. 5.3.1 Global Donepezil Hydrochloride Tablet Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Donepezil Hydrochloride Tablet Revenue by Application (2021-2032)
  12. 5.3.3 Global Donepezil Hydrochloride Tablet Revenue Market Share by Application (2021-2032)
6 Global Donepezil Hydrochloride Tablet Sales by Region
  1. 6.1 Global Donepezil Hydrochloride Tablet Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Donepezil Hydrochloride Tablet Sales by Region (2021-2032)
  3. 6.2.1 Global Donepezil Hydrochloride Tablet Sales by Region (2021-2026)
  4. 6.2.2 Global Donepezil Hydrochloride Tablet Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Donepezil Hydrochloride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Donepezil Hydrochloride Tablet Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Donepezil Hydrochloride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Donepezil Hydrochloride Tablet Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Donepezil Hydrochloride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Donepezil Hydrochloride Tablet Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Donepezil Hydrochloride Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Donepezil Hydrochloride Tablet Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Donepezil Hydrochloride Tablet Revenue by Region
  1. 7.1 Global Donepezil Hydrochloride Tablet Revenue by Region
  2. 7.1.1 Global Donepezil Hydrochloride Tablet Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Donepezil Hydrochloride Tablet Revenue by Region (2021-2026)
  4. 7.1.3 Global Donepezil Hydrochloride Tablet Revenue by Region (2027-2032)
  5. 7.1.4 Global Donepezil Hydrochloride Tablet Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Donepezil Hydrochloride Tablet Revenue (2021-2032)
  8. 7.2.2 North America Donepezil Hydrochloride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Donepezil Hydrochloride Tablet Revenue (2021-2032)
  11. 7.3.2 Europe Donepezil Hydrochloride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Donepezil Hydrochloride Tablet Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Donepezil Hydrochloride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Donepezil Hydrochloride Tablet Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Donepezil Hydrochloride Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai
  2. 8.1.1 Eisai Company Information
  3. 8.1.2 Eisai Business Overview
  4. 8.1.3 Eisai Donepezil Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eisai Donepezil Hydrochloride Tablet Product Portfolio
  6. 8.1.5 Eisai Recent Developments
  7. 8.2 Luoxin Pharmaceutical
  8. 8.2.1 Luoxin Pharmaceutical Company Information
  9. 8.2.2 Luoxin Pharmaceutical Business Overview
  10. 8.2.3 Luoxin Pharmaceutical Donepezil Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Luoxin Pharmaceutical Donepezil Hydrochloride Tablet Product Portfolio
  12. 8.2.5 Luoxin Pharmaceutical Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Donepezil Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Donepezil Hydrochloride Tablet Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Huahai Pharmaceutical
  20. 8.4.1 Huahai Pharmaceutical Company Information
  21. 8.4.2 Huahai Pharmaceutical Business Overview
  22. 8.4.3 Huahai Pharmaceutical Donepezil Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Huahai Pharmaceutical Donepezil Hydrochloride Tablet Product Portfolio
  24. 8.4.5 Huahai Pharmaceutical Recent Developments
  25. 8.5 Hansoh Pharma
  26. 8.5.1 Hansoh Pharma Company Information
  27. 8.5.2 Hansoh Pharma Business Overview
  28. 8.5.3 Hansoh Pharma Donepezil Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hansoh Pharma Donepezil Hydrochloride Tablet Product Portfolio
  30. 8.5.5 Hansoh Pharma Recent Developments
  31. 8.6 Hisun Pharmaceutical
  32. 8.6.1 Hisun Pharmaceutical Company Information
  33. 8.6.2 Hisun Pharmaceutical Business Overview
  34. 8.6.3 Hisun Pharmaceutical Donepezil Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hisun Pharmaceutical Donepezil Hydrochloride Tablet Product Portfolio
  36. 8.6.5 Hisun Pharmaceutical Recent Developments
  37. 8.7 ARK PHA.LTD
  38. 8.7.1 ARK PHA.LTD Company Information
  39. 8.7.2 ARK PHA.LTD Business Overview
  40. 8.7.3 ARK PHA.LTD Donepezil Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ARK PHA.LTD Donepezil Hydrochloride Tablet Product Portfolio
  42. 8.7.5 ARK PHA.LTD Recent Developments
  43. 8.8 Lupin
  44. 8.8.1 Lupin Company Information
  45. 8.8.2 Lupin Business Overview
  46. 8.8.3 Lupin Donepezil Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lupin Donepezil Hydrochloride Tablet Product Portfolio
  48. 8.8.5 Lupin Recent Developments
  49. 8.9 Globalstar
  50. 8.9.1 Globalstar Company Information
  51. 8.9.2 Globalstar Business Overview
  52. 8.9.3 Globalstar Donepezil Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Globalstar Donepezil Hydrochloride Tablet Product Portfolio
  54. 8.9.5 Globalstar Recent Developments
  55. 8.10 G Med Impex
  56. 8.10.1 G Med Impex Company Information
  57. 8.10.2 G Med Impex Business Overview
  58. 8.10.3 G Med Impex Donepezil Hydrochloride Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 G Med Impex Donepezil Hydrochloride Tablet Product Portfolio
  60. 8.10.5 G Med Impex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Donepezil Hydrochloride Tablet Value Chain Analysis
  2. 9.1.1 Donepezil Hydrochloride Tablet Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Donepezil Hydrochloride Tablet Production Mode & Process
  6. 9.2 Donepezil Hydrochloride Tablet Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Donepezil Hydrochloride Tablet Distributors
  9. 9.2.3 Donepezil Hydrochloride Tablet Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research